A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment

Clinical trial NCT01994057 · RECRUITING

Trial details

NCT number: NCT01994057
Sponsor: Sun Yat-sen University
Status: RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer (NSCLC)EGFR-TKI Resistant Mutation EGFR-TKI Sensitizing Mutation Germline Mutations Somatic Mutation

Start date: 2012-09-01
Primary completion: 2025-10-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.